Publication | Open Access
Real-World Experience Treating Pediatric Epilepsy Patients With Cenobamate
43
Citations
7
References
2022
Year
Cenobamate is an effective ASM for pediatric patients suffering from drug-resistant epilepsy. In addition to excellent seizure reduction or freedom, it is well-tolerated. Cenobamate should be considered as a novel treatment for DRE in pediatric patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1